VIOLATIONS OF CYTOKINE REGULATION IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY

VIOLATIONS OF CYTOKINE REGULATION IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY

Purpose. To study the content of the transforming growth factorbeta 2 (TGF-β2), vascular endothelial growth factor (VEGF), pigment epithelium factor (PEDF) and several cytokines in the vitreous body in patients with proliferative diabetic retinopathy (PDR), to evaluate an activity of proliferative a...

Full description

Bibliographic Details
Main Authors:	D. V. Chernykh, E. V. Smirnov, O. M. Gorbenko, A. P. Shvayuk, O. O. Obuhova, L. A. Trunova, V. V. Chernykh, A. N. Trunov
Format:	Article
Language:	Russian
Published:	Publishing house "Ophthalmology" 2015-10-01
Series:	Офтальмохирургия
Subjects:	proliferative diabetic retinopathy inflammation proliferation cytokines growth factors
Online Access:	https://www.ophthalmosurgery.ru/jour/article/view/94

Similar Items

WTH FACTORS IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: A. N. Trunov, et al.
Published: (2017-04-01)

Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy
by: Yoshida S, et al.
Published: (2017-09-01)

VEGF and eNOS genes polymorphism features in patients with diabetes mellitus with and without initial non-proliferative diabetic retinopathy
by: A. V. Shevchenko, et al.
Published: (2021-12-01)

Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy
by: Otilia Obadă, et al.
Published: (2022-07-01)

ANGIOGENESIS IN PROLIFERATIVE DIABETIC RETINOPATHY: RERSPECTIVES OF ANTI-VEGF THERAPY (REVIEW OF LITERATURE)
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01)

Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy
by: Shuang Li, et al.
Published: (2012-12-01)

Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign
by: Hoon Park, et al.
Published: (2014-02-01)

Vitrectomy combined with cataract surgery in the treatment of proliferative diabetic retinopathy
by: Yan-Feng Yang, et al.
Published: (2018-02-01)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
by: V V Chernykh, et al.
Published: (2015-01-01)

EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
by: O. M. Trubina, et al.
Published: (2016-11-01)

LOCAL AND SYSTEMIC VEGF-А PRODUCTION IN COMPLICATED PROLIFERATIVE DIABETIC RETINOPATHY
by: V. V. Neroev, et al.
Published: (2016-08-01)

Retrospective analysis of surgical treatment on proliferative diabetic retinopathy in the elderly
by: Cui-Li Zhang, et al.
Published: (2015-11-01)

Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes
by: Zhang M, et al.
Published: (2023-01-01)

Role of hyperhomocysteinemia in proliferative diabetic retinopathy: A case–control study
by: Prabha Gupta, et al.
Published: (2018-01-01)

Treatment of proliferative diabetic retinopathy by vitrectomy combined with retinal photocoagulation
by: Jun Jia, et al.
Published: (2014-05-01)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
by: Lei Shi, et al.
Published: (2012-01-01)

Cytokines and growth factors in the pathogenesis of primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2020-10-01)

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
by: Prajina Rahul, et al.
Published: (2016-01-01)

Pattern scan laser versus single spot laser in panretinal photocoagulation treatment for proliferative diabetic retinopathy
by: Shu Zhang, et al.
Published: (2017-02-01)

Efficacy of the modified staged method of surgical treatment for proliferative diabetic retinopathy
by: Vira S Ponomarchuk, et al.
Published: (2022-03-01)

Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment
by: Anikó Balogh, et al.
Published: (2020-12-01)

Upregulation of PCED1B-AS1 in proliferative diabetic retinopathy and its involvement in retinal vascular endothelial cell proliferation
by: Xuyang Wang, et al.
Published: (2022-11-01)

Outcomes of aflibercept for post-vitrectomy vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: O. O. Putienko, et al.
Published: (2021-06-01)

Interplay of endothelial-mesenchymal transition, inflammation, and autophagy in proliferative diabetic retinopathy pathogenesis
by: Gaocheng Zou, et al.
Published: (2024-02-01)

Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-02-01)

Local and systemic erythropoietin levels in complicated proliferative diabetic retinopathy
by: V. V. Neroev, et al.
Published: (2018-10-01)

Different Mechanisms Causing Macular Hole Development in Proliferative Diabetic Retinopathy
by: Sinan Tatlıpınar
Published: (2012-05-01)

Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
by: Jian-Bo Mao, et al.
Published: (2018-07-01)

Reasons for the Late Presentation of Diabetic Retinopathy in Saudi Arabia: A Survey of Patients Who Presented with Advanced Proliferative Diabetic Retinopathy to a Tertiary Eye Hospital
by: Al-Shehri AM, et al.
Published: (2022-12-01)

Clinical and experimental study on angiopoietin-like protein 8 associated with proliferative diabetic retinopathy
by: Chang-Xia Dong, et al.
Published: (2017-12-01)

Effect of anti-vascular endothelial growth factor therapy on intraocular inflammatory cytokine levels in the treatment of proliferative diabetic retinopathy
by: Jin-Xiu Luo, et al.
Published: (2023-05-01)

Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy
by: Yian Guo, MS, et al.
Published: (2023-06-01)

“String of beads” appearance on fundus fluorescein angiography as a clinical clue for leukemia-related proliferative retinopathy
by: B V Priya, et al.
Published: (2019-01-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
by: Sakamoto M, et al.
Published: (2018-11-01)

Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis
by: Qian-Hui Yang, et al.
Published: (2019-02-01)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
by: Albert L Lin, et al.
Published: (2020-10-01)